Cargando…

Aberrant Expression of NCAPG is Associated with Prognosis and Progression of Gastric Cancer

INTRODUCTION: Gastric cancer (GC), one of the most prevalent malignancies, is the third-leading cause of cancer-related deaths globally. The aim of this study is to investigate the involvement of non-structural maintenance of chromosomes condensin I complex subunit G (NCAPG) in the prognosis of GC....

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Ding-Ping, Lin, Chih-Chan, Hung, Shih-Ting, Kuang, Yi-Yu, Hseu, You-Cheng, Fang, Chia-Lang, Lin, Kai-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457733/ https://www.ncbi.nlm.nih.gov/pubmed/32922082 http://dx.doi.org/10.2147/CMAR.S248318

Ejemplares similares

Ubiquitin‐specific protease 3 overexpression promotes gastric carcinogenesis and is predictive of poor patient prognosis
por: Fang, Chia‐Lang, et al.
Publicado: (2018)

Loss of cyclin‐dependent kinase‐like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasion
por: Fang, Chia‐Lang, et al.
Publicado: (2018)

GRK3 as a Prognosis Biomarker in Gastric Cancer
por: Fang, Chia-Lang, et al.
Publicado: (2022)

Galectin-1-mediated high NCAPG expression correlates with poor prognosis in gastric cancer
por: Zheng, Tingrui, et al.
Publicado: (2023)

Clinical and Prognostic Association of Transcription Factor SOX4 in Gastric Cancer
por: Fang, Chia-Lang, et al.
Publicado: (2012)

EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer
por: Sun, Ding-Ping, et al.
Publicado: (2017)

Clinicopathologic and Prognostic Significance of Thymopoietin-α Overexpression in Gastric Cancer
por: Sun, Ding-Ping, et al.
Publicado: (2019)

NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
por: Wu, Yun, et al.
Publicado: (2021)

Overexpression of Mitochondrial GTPase MFN2 Represents a Negative Prognostic Marker in Human Gastric Cancer and Its Inhibition Exerts Anti-Cancer Effects
por: Fang, Chia-Lang, et al.
Publicado: (2017)

Increased expression of NCAPG (Non-SMC condensing I complex subunit G) is associated with progression and poor prognosis of lung adenocarcinoma
por: Wang, Xiaodong, et al.
Publicado: (2022)

NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma
por: Zheng, Guangrong, et al.
Publicado: (2022)

PLAG1 and NCAPG‐LCORL in livestock
por: Takasuga, Akiko
Publicado: (2016)

Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer
por: Xu, Tao, et al.
Publicado: (2020)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma
por: Zhan, Ping, et al.
Publicado: (2016)

Pan-cancer analysis of the immune aspects and prognostic value of NCAPG2
por: Feng, Huidong, et al.
Publicado: (2023)

NCAPG as a novel prognostic biomarker in numerous cancers: a meta-analysis and bioinformatics analysis
por: Lin, Jie, et al.
Publicado: (2023)

VAV3 Oncogene Expression in Colorectal Cancer: Clinical Aspects and Functional Characterization
por: Uen, Yih-Huei, et al.
Publicado: (2015)

NCAPG Is a Promising Therapeutic Target Across Different Tumor Types
por: Xiao, Cuicui, et al.
Publicado: (2020)

Characterizing the Crosstalk of NCAPG with Tumor Microenvironment and Tumor Stemness in Stomach Adenocarcinoma
por: Xiang, Zheng, et al.
Publicado: (2022)

NCAPG stimulates lung adenocarcinoma cell stemness through aerobic glycolysis
por: Zhang, Zuwang, et al.
Publicado: (2023)

AC099850.3/NCAPG Axis Predicts Poor Prognosis and is Associated with Resistance to EGFR Tyrosine-Kinase Inhibitors in Lung Adenocarcinoma
por: Bao, Jiaqi, et al.
Publicado: (2022)

NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression
por: Sun, Huanhuan, et al.
Publicado: (2022)

NCAPG Dynamically Coordinates the Myogenesis of Fetal Bovine Tissue by Adjusting Chromatin Accessibility
por: Hu, Xin, et al.
Publicado: (2020)

NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma
por: Jiang, Shiyao, et al.
Publicado: (2022)

NCAPG promotes the proliferation of hepatocellular carcinoma through the CKII-dependent regulation of PTEN
por: Zhang, Rongguiyi, et al.
Publicado: (2022)

NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer
por: Jiang, Lili, et al.
Publicado: (2020)

Clinical and Prognostic Implications of Transcription Factor SOX4 in Patients with Colon Cancer
por: Lin, Chun-Mao, et al.
Publicado: (2013)

Correction: NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression
por: Sun, Huanhuan, et al.
Publicado: (2022)

MicroRNA‑181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG
por: Ai, Jiyuan, et al.
Publicado: (2019)

NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling
por: Gong, Chengwu, et al.
Publicado: (2019)

NCAPG Promotes the Proliferation of Renal Clear Cell Carcinoma via Mediating with CDK1
por: Li, Huibing, et al.
Publicado: (2022)

Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth
por: Wang, Yu, et al.
Publicado: (2019)

NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma
por: Ren, Wenjun, et al.
Publicado: (2022)

Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer
por: Song, Bin, et al.
Publicado: (2018)

NCAPG upregulation mediated by four microRNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer
por: Dong, Menglu, et al.
Publicado: (2021)

Identification of three predictors of gastric cancer progression and prognosis
por: Huang, Kai, et al.
Publicado: (2020)

FOXM1/lncRNA TYMSOS/miR-214-3p–Mediated High Expression of NCAPG Correlates With Poor Prognosis and Cell Proliferation in Non–Small Cell Lung Carcinoma
por: Yuan, Yixiao, et al.
Publicado: (2022)

Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer
por: Yeh, Chung-Min, et al.
Publicado: (2016)

NCAPG Induces Cell Proliferation in Cardia Adenocarcinoma via PI3K/AKT Signaling Pathway
por: Zhang, Xinxin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dfop4vcsqg3agegb5u9mfc2rq2